RESPONSE GENETICS INC - 76123U105
Sector:
Healthcare
· Industry:
In Vitro & In Vivo Diagnostic Substances
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2014
· Q4 2013
Value (USD)
Total reported value ($000)
$21.43M
QoQ value delta ($000)
+$659K
(+3.17%)
Implied price effect (QoQ)
+2.58%
Shares
Total shares
18,007,088
QoQ shares delta
+102,709
(+0.57%)
Total shares held by funds (by quarter)
Top holders (Q1 2014)
Top 25 only
Full list
Early Q2 2014 data: only 3 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 7,140 | 6,000,000 | 0.48% |
| LANSDOWNE PARTNERS LIMITED PARTNERSHIP | 4,528 | 3,805,161 | 0.04% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 3,188 | 2,679,179 | 0.35% |
| 12 West Capital Management LP | 2,913 | 2,447,617 | 0.47% |
| Becker Drapkin Management, L.P. | 2,407 | 2,022,890 | 1.51% |
| VANGUARD GROUP INC | 775 | 651,091 | 0.0% |
| BlackRock Fund Advisors | 131 | 109,847 | 0.0% |
| FIRST MANHATTAN CO | 107 | 90,496 | 0.0% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 60 | 49,400 | 0.0% |
| GOLDMAN SACHS GROUP INC | 42 | 35,124 | 0.0% |
| NORTHERN TRUST CORP | 41 | 34,527 | 0.0% |
| KCG Holdings, Inc. | 25 | 21,548 | 0.0% |
| DOMINI SOCIAL INVESTMENTS LLC | 24 | 20,147 | 1.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 17 | 15,003 | 0.0% |
| GUGGENHEIM CAPITAL LLC | 15 | 12,778 | 0.0% |
| SUMMIT CAPITAL MANAGEMENT LLC | 12 | 10,000 | 0.0% |
| CITIGROUP INC | 1 | 1,050 | 0.0% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1 | 553 | 0.0% |
| MORGAN STANLEY | 0 | 65 | 0.0% |
| BNP PARIBAS ARBITRAGE, SA | 0 | 612 | 0.0% |